Literature DB >> 25933264

Pre-exposure prophylaxis works--it's time to deliver.

Chris Beyrer1, Linda-Gail Bekker2, Anton Pozniak3, Françoise Barré-Sinoussi4.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25933264     DOI： 10.1016/S0140-6736(15)60724-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Implementation and assessment of a model to increase HIV testing among men who have sex with men and transgender women in Thailand, 2011-2016.

Authors:  Montinee Wasantioopapokakorn; Chomnad Manopaiboon; Thanongsri Phoorisri; Akechittra Sukkul; Cheewanan Lertpiriyasuwat; Sumet Ongwandee; Farida Langkafah; Usanee Kritsanavarin; Prin Visavakum; Bongkoch Jetsawang; Somboon Nookhai; Prapaporn Kitwattanachai; Wanwimon Weerawattanayotin; Mana Losirikul; Naruemon Yenyarsun; Nuchapong Jongchotchatchawal; Michael Martin
Journal:  AIDS Care       Date:  2018-06-27

2.  Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.

Authors:  Bohdan Nosyk; Jeong E Min; Viviane D Lima; Robert S Hogg; Julio S G Montaner
Journal:  Lancet HIV       Date:  2015-07-16       Impact factor: 12.767

3.  Healthcare Provider Contact and Pre-exposure Prophylaxis in Baltimore Men Who Have Sex With Men.

Authors:  Julia R G Raifman; Colin Flynn; Danielle German
Journal:  Am J Prev Med       Date:  2016-09-20       Impact factor: 5.043

4.  Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.

Authors:  Linda-Gail Bekker; Surita Roux; Elaine Sebastien; Ntando Yola; K Rivet Amico; James P Hughes; Mark A Marzinke; Craig W Hendrix; Peter L Anderson; Vanessa Elharrar; Michael Stirratt; James F Rooney; Estelle Piwowar-Manning; Susan H Eshleman; Laura McKinstry; Maoji Li; Bonnie J Dye; Robert M Grant
Journal:  Lancet HIV       Date:  2017-10-03       Impact factor: 12.767

Review 5.  Ending the HIV/AIDS epidemic in low- and middle-income countries by 2030: is it possible?

Authors:  Anthony D Harries; Amitabh B Suthar; Kudakwashe C Takarinda; Hannock Tweya; Nang Thu Thu Kyaw; Katie Tayler-Smith; Rony Zachariah
Journal:  F1000Res       Date:  2016-09-15

6.  The intention to use HIV-pre-exposure prophylaxis (PrEP) among men who have sex with men in Switzerland: testing an extended explanatory model drawing on the unified theory of acceptance and use of technology (UTAUT).

Authors:  Sibylle Nideröst; Daniel Gredig; Benedikt Hassler; Franziska Uggowitzer; Patrick Weber
Journal:  Z Gesundh Wiss       Date:  2017-11-22

7.  The pre-exposure prophylaxis (PrEP) consciousness of black college women and the perceived hesitancy of public health institutions to curtail HIV in black women.

Authors:  Rasheeta Chandler; Shawnika Hull; Henry Ross; Dominique Guillaume; Sudeshna Paul; Nikita Dera; Natalie Hernandez
Journal:  BMC Public Health       Date:  2020-07-28       Impact factor: 3.295

8.  Meeting report: South African Medical Research Council Standard of Care in Clinical Research in Low- And Middle-Income Settings Summit, November 2017.

Authors:  Maurine D Miner; Linda-Gail Bekker; Tamara Kredo; Niresh Bhagwandin; Lawrence Corey; Glenda E Gray
Journal:  Trials       Date:  2021-11-06       Impact factor: 2.728

9.  Let Me Prep You to PREP Me: Amplifying the Voices of Black Women and Their Providers to Consider PrEP as an HIV Prevention Option.

Authors:  Rasheeta Chandler; Dominique Guillaume; Jessica Wells; Natalie Hernandez
Journal:  Int J Environ Res Public Health       Date:  2022-01-27       Impact factor: 3.390

10.  Who Will Use Pre-Exposure Prophylaxis (PrEP) and Why?: Understanding PrEP Awareness and Acceptability amongst Men Who Have Sex with Men in the UK--A Mixed Methods Study.

Authors:  Jamie Frankis; Ingrid Young; Paul Flowers; Lisa McDaid
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.